← Eichor
Study identifier: NCT05313165 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Condition: Critical Limb Ischemia · Chronic Limb-Threatening Ischemia · Peripheral Arterial Disease  ·  Sponsor: LimFlow, Inc.

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 95 Years
Healthy volunteersNo

About this study

A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

This description comes directly from the study's public registry record.

Talk to the study team

Erin Towery  ·  888-478-7705  ·  etowery@limflow.com

Always discuss trial participation with your own doctor first.

Locations (30)

University of California, San Diego HealthLa Jolla, California, United StatesWithdrawn
Stanford University School of MedicinePalo Alto, California, United StatesCompleted
UCSFSan Francisco, California, United StatesCompleted
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterTorrance, California, United StatesCompleted
Yale UniversityNew Haven, Connecticut, United StatesCompleted
The Cardiac and Vascular InstituteGainesville, Florida, United StatesRecruiting
University of FloridaGainesville, Florida, United StatesCompleted
Tallahassee Research InstituteTallahassee, Florida, United StatesWithdrawn
Rush University Medical CenterChicago, Illinois, United StatesCompleted
Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Boston Medical CenterBoston, Massachusetts, United StatesWithdrawn
UMass Chan Medical SchoolWorcester, Massachusetts, United StatesCompleted

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05313165